GBP/USD 1.354 EUR/GBP 0.863 GBP/JPY 199.657 EUR/USD 1.169 GBP/AUD 2.080 USD/JPY 147.405 USD/CAD 1.380 AUD/USD 0.651 CAD/JPY 106.850 EUR/CAD 1.612 GBP/CAD 1.869 AUD/CAD 0.898 AUD/JPY 95.984 AUD/NZD 1.097 EUR/AUD 1.795 GBP/USD 1.354 EUR/GBP 0.863 GBP/JPY 199.657 EUR/USD 1.169 GBP/AUD 2.080 USD/JPY 147.405 USD/CAD 1.380 AUD/USD 0.651 CAD/JPY 106.850 EUR/CAD 1.612 GBP/CAD 1.869 AUD/CAD 0.898 AUD/JPY 95.984 AUD/NZD 1.097 EUR/AUD 1.795
CURRENCY .wiki

Finance News – Drugmaker

What is your interest today?

Financial Times • Jul 30, 2025

How Novo Nordisk lost its lead in the weight loss race

Novo Nordisk faced challenges meeting surging demand and navigating a market heavily influenced by celebrity endorsements, which impacted its financial performance and competitive...

Read Full Article →
MarketWatch Top Stories • Jul 29, 2025

Novo Nordisk issues profit warning as competition — legal and otherwise — hits Wegovy, Ozempic

Novo Nordisk lowered its forecast due to increasing challenges from various competitors, leading to a decline in its stock value and signaling potential impacts on the company's fu...

Read Full Article →
Investopedia • Jul 16, 2025

Sarepta Therapeutics Stock Soars on Beleaguered Drugmaker's Restructuring Plan

The company’s recent organizational changes have led to increased investor confidence, resulting in a notable rise in its market valuation and trading activity.

Read Full Article →
CNBC Business • May 22, 2025

We’re adding to our position in this out-of-favor, high-quality drugmaker stock

Investing more in this pharmaceutical company, currently valued lower than usual and trading at a modest multiple of projected 2026 earnings, suggests the market may have accounted...

Read Full Article →
Investopedia • May 22, 2025

Vigil Neuroscience Stock Triples as Drugmaker Agrees to Acquisition by Sanofi

The company's market value increased significantly after the announcement of its upcoming purchase by a major pharmaceutical firm, highlighting investor confidence in the potential...

Read Full Article →